Biosimilar Development Meetings At US FDA Not Just For Talking Similarity

 
• By Sue Sutter
  
Woman listens
US FDA is listening when biosimilar sponsors raise manufacturing and other issues during product development meetings.
Pink Sheet Podcast

Learn what's happening at the US FDA. On the go.

Derrick Gingery and the team bring you a weekly "Drug Fix".

SpotifyApple PodcastsWebsite

More from Biosimilars

More from Biosimilars & Generics